Início › Câncer de Próstata › Oregon
Ensaios clínicos de Câncer de Próstata em Oregon
38 estudos para Câncer de Próstata estão buscando participantes em locais em Oregon.
Cidades em Oregon
Texto oficial do estudo (Inglês)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Oregon Health & Science University (OHSU), Portland
RecrutandoFase 1/2
Idades 12 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT04585750Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 2 de out. de 2026 · NCT07200830Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Saint Alphonsus Cancer Care Center-Baker City, Baker City
- Saint Charles Health System, Bend
- Clackamas Radiation Oncology Center, Clackamas
- e mais 7
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades de 40 a 75 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05334069Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Oregon Health and Science University, Portland
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06632977Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Saint Alphonsus Cancer Care Center-Ontario, Ontario
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- e mais 1
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT03866382Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
- Oregon Health & Science University, Portland
RecrutandoFase 4
Idades 18 e acima · Homens · Atualizado em 29 de set. de 2026 · NCT07569926A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
- Oregon Health And Science University, Portland
RecrutandoFase 1
Idades 18 e acima · Homens · Atualizado em 28 de set. de 2026 · NCT06095089Precision-Based Genomics in Prostate Cancer
- Oregon Health Sciences University, Portland
RecrutandoEstudo observacional
Idades de 18 a 120 · Homens · Atualizado em 28 de set. de 2026 · NCT04706663A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread
- Providence Portland Medical Center, Portland
RecrutandoFase 1
Idades 18 e acima · Homens · Atualizado em 24 de set. de 2026 · NCT07543055Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- Oregon Urology Institute, Springfield
RecrutandoFase 2/3
Idades de 18 a 100 · Homens · Atualizado em 22 de set. de 2026 · NCT06780670A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- Oregon Oncology Specialists, Salem
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 22 de set. de 2026 · NCT07213674A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Research Site, Springfield
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 18 de set. de 2026 · NCT06952803High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
- VA Portland Health Care System, Portland, OR, Portland
RecrutandoFase 2
Idades 18 e acima · Homens · Atualizado em 17 de set. de 2026 · NCT05011383Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
- VA Portland Health Care System, Portland, OR, Portland
RecrutandoFase 2
Idades 18 e acima · Homens · Atualizado em 17 de set. de 2026 · NCT04038502A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- VA Portland Health Care System ( Site 0038), Portland
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 17 de set. de 2026 · NCT06925737Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- Oregon Urology, Springfield
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 11 de set. de 2026 · NCT06056830Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Saint Charles Health System, Bend
- Clackamas Radiation Oncology Center, Clackamas
- Providence Portland Medical Center, Portland
- e mais 2
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 10 de set. de 2026 · NCT05946213MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy
- Oregon Health & Science University, Portland
Recrutando
Idades 18 e acima · Homens · Atualizado em 1 de set. de 2026 · NCT05710380A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
- Oregon Health & Science University, Portland
RecrutandoFase 2
Idades 18 e acima · Homens · Atualizado em 31 de ago. de 2026 · NCT05726292Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
- Research Site, Portland
RecrutandoFase 1/2
Idades de 18 a 99 · Homens · Atualizado em 27 de ago. de 2026 · NCT07590934AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Research Site, Portland
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 26 de ago. de 2026 · NCT07611110A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
- VA Portland Health Care System, Portland, OR, Portland
RecrutandoFase 2
Idades 18 e acima · Homens · Atualizado em 25 de ago. de 2026 · NCT05593497Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Saint Charles Health System, Bend
- Clackamas Radiation Oncology Center, Clackamas
- Bay Area Hospital, Coos Bay
- e mais 5
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 19 de ago. de 2026 · NCT04423211FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Oregon Health and Science University, Portland
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT05919264Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Saint Charles Health System, Bend
- Clackamas Radiation Oncology Center, Clackamas
- Bay Area Hospital, Coos Bay
- e mais 8
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 14 de jul. de 2026 · NCT06592924A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
- Oregon Health & Science University, Portland
RecrutandoFase 1/2
Idades 18 e acima · Homens · Atualizado em 25 de jun. de 2026 · NCT06457919Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
- VA Portland Health Care System, Portland
RecrutandoFase 2
Idades 18 e acima · Homens · Atualizado em 15 de jun. de 2026 · NCT05422911International Registry for Men With Advanced Prostate Cancer (IRONMAN)
- Oregon Health & Science University Hospital, Portland
RecrutandoEstudo observacional
Idades 21 e acima · Homens · Atualizado em 22 de mai. de 2026 · NCT03151629Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
- OHSU Knight Cancer Institute, Portland
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades 40 e acima · Homens · Atualizado em 15 de mai. de 2026 · NCT04472338A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
- Research Site, Portland
RecrutandoFase 1
Idades 18 e acima · Homens · Atualizado em 12 de mai. de 2026 · NCT06879041Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVE
- OHSU Knight Cancer Institute, Portland
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 8 de mai. de 2026 · NCT06011499GET FIT Together: Testing a Socially Enhanced Exercise Program in Older Men With Prostate Cancer
- OHSU Knight Cancer Institute, Portland
Recrutando
Idades 65 e acima · Homens · Atualizado em 6 de mai. de 2026 · NCT07504835Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
- Saint Alphonsus Medical Center-Baker City, Baker City
- Saint Charles Health System, Bend
- Clackamas Radiation Oncology Center, Clackamas
- e mais 9
RecrutandoFase 2
Idades 18 e acima · Homens · Atualizado em 29 de jan. de 2026 · NCT05806515Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
- Saint Alphonsus Cancer Care Center-Baker City, Baker City
- Saint Alphonsus Cancer Care Center-Ontario, Ontario
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 22 de jan. de 2026 · NCT06470243cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Oregon Health Sciences University, Portland
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades 40 e acima · Todos os sexos · Atualizado em 20 de jan. de 2026 · NCT05366881SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Portland
RecrutandoEstudo observacional
Todas as idades · Todos os sexos · Atualizado em 28 de out. de 2025 · NCT03452774EMBRACE: Exercising Together
- OHSU Knight Cancer Institute, Portland
RecrutandoFase 2Voluntários saudáveis bem-vindos
Idades 18 e acima · Todos os sexos · Atualizado em 29 de mai. de 2025 · NCT06049355Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer
- VA Portland Healthcare System, Portland
RecrutandoFase 2
Idades 18 e acima · Homens · Atualizado em 20 de abr. de 2022 · NCT03753243Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.